Skip to main content
JHS Svendgaard Laboratories Ltd. logo

JHS Svendgaard Laboratories Ltd. — Investor Relations & Filings

Ticker · JHS ISIN · INE544H01014 LEI · 335800NYNAOOMRTTWW75 BSE.NS Manufacturing
Open in API
Filings indexed 678 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country IN India
Listing BSE.NS JHS

About JHS Svendgaard Laboratories Ltd.

https://www.svendgaard.com/

JHS Svendgaard Laboratories Ltd. is a specialized manufacturer of oral care products, operating primarily through contract manufacturing and private labeling arrangements. The company provides end-to-end solutions for oral hygiene, including the production of toothbrushes, toothpastes, mouthwashes, and specialized dental care items. It maintains large-scale manufacturing facilities equipped to handle high-volume production for global and domestic FMCG brands. In addition to its business-to-business operations, the company manages its own consumer brand, Aquawhite, which focuses on innovative oral care solutions for various age groups, including a significant range of licensed character-based products for children. The organization emphasizes quality control and technical expertise in oral health product development, catering to diverse market segments through a robust supply chain and distribution network.

Recent filings

Filing Released Lang Actions
Statement of Deviation for Quarter ended 31 March, 2026.
Regulatory Filings Classification · 85% confidence The document is a formal regulatory disclosure submitted under SEBI (Listing Obligations and Disclosure Requirements) Regulation 32, providing the Statement of Deviation or Variation in utilization of preferential issue funds for the quarter ended March 31, 2026. It does not contain full financial statements or constitute an earnings release, interim report, or audit report. It is a mandatory compliance announcement rather than a capital raising announcement or an investor presentation. Therefore, it best fits the catch-all “Regulatory Filings” category.
2026-05-26 English
Audited Financial Result for quarter and year ended 31 March, 2026.
Interim / Quarterly Report Classification · 85% confidence The document is a regulatory filing under SEBI Listing Regulations (Reg. 33) notifying stock exchanges of the Board’s approval of the audited financial results for the quarter and year ended March 31, 2026. It encloses the standalone and consolidated financial results and the external auditor’s report. This constitutes the company’s periodic (quarterly and year‐end) financial statements rather than a full annual report narrative, management changes, or a simple announcement. Therefore, it should be classified as an interim/quarterly report. FY 2026
2026-05-26 English
The Board of Directors of the company inter alia, considered and approved the Audited Financial Results of the Company for the quarter and financial year ended March 31, 2025 today in its ....
Audit Report / Information Classification · 85% confidence The document is a combined SEBI board meeting outcome notice along with the full Independent Auditor’s Report on the standalone financial statements for the year ending March 31, 2026. It is not a full annual report (10-K), nor merely a brief earnings highlight (ER), nor a standard interim presentation — instead it includes the complete statutory audit report. Under our definitions, this constitutes a standalone Audit Report/Information filing (AR).
2026-05-26 English
Outcome of Board Meeting
Audit Report / Information Classification · 87% confidence The document is a stock exchange filing under SEBI LODR Reg. 33 notifying the outcome of the Board Meeting and attaching the Audited Financial Results (quarter & year ended March 31, 2026) along with the Independent Auditor’s Report. This is not a full Annual Report (10‐K) or mere earnings highlight, but rather the auditor’s standalone report on the financial statements (with unmodified opinion and key audit matters). It therefore falls under Audit Report / Information (AR).
2026-05-26 English
Annual Secretarial Compliance report for the Year Ended 31st March, 2026
Regulatory Filings Classification · 88% confidence The document is a Secretarial Compliance Report under SEBI LODR Regulations, signed by the Practicing Company Secretary, certifying compliance with listing obligations. It is an officer certification/attestation rather than a financial report (10-K/IR) or a management presentation. Under the CERTIFICATION RULE, such compliance certificates fall under Regulatory Filings (RNS) as a general regulatory submission and fallback category.
2026-05-26 English
JHS Svendgaard Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2026 ,inter alia, to consider and approve Audited Financial ....
Regulatory Filings Classification · 85% confidence The document is a formal intimation under SEBI LODR Regulation 29 notifying stock exchanges of a scheduled Board meeting to consider and approve audited financial results. It does not contain any financial statements itself nor announce the publication of a report, nor report a change in board composition. This is a regulatory/compliance announcement and falls under the catch-all “Regulatory Filings” category (RNS).
2026-05-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.